Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
688505.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.46B
Close$
$1.65
79.8% downside
Current Fair Value
79.8% downsideOvervalued by 79.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.46 Billion |
|---|---|
| Enterprise Value | $7.25 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.15 |
| Beta | 0.09 |
| Outstanding Shares | 1,036,572,100 |
Return
| Return on Equity | -5.87% |
|---|---|
| Return on Assets | -5.23% |
| Return on Invested Capital | -5.27% |
Valuation & Multiples
| P/E Ratio | -69.72 |
|---|---|
| PEG | -8.14 |
| Price to Sales | - |
| Price to Book Ratio | 4.08 |
| Enterprise Value to Revenue | -0.37 |
| Enterprise Value to EBIT | 2.14 |
| Enterprise Value to Net Income | -58 |
| Total Debt to Enterprise | -0.07 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
833 employees
CEO: Da Jun Zhao Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., along with its affiliated entities, is dedicated to the research, development, production, and commercialization of biopharmaceutical products. The company leverages its genetic eng...